On average, 3,256 women are diagnosed with cervical cancer each year, with 99.8% of cases being preventable. This translates to about 402,000 samples annually. Our RFID sample tracking at the specimen level boosts efficiency, lowers costs, and eliminates unnecessary re-tests. This technology plays a crucial role in upholding sample integrity and enhancing the screening process for women.
Commentaires